Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Image of the MS-UK Helpline button graphic containing a link to the Helpline page

Image of the New Pathways magazine button graphic containing a link to the New Pathways magazine page


Researchers in Australia have identified the first blood biomarker – a chemical identifier in the blood – for multiple sclerosis (MS). 

The findings are the result of a 12 year study that...

Results of a new clinical trial have provided evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained...

The Scottish Government is working with The University of the West of Scotland (UWS) to fund two PhDs in multiple sclerosis (MS), with the university funding a further two places for the...

Statistically more women than men develop multiple sclerosis (MS), but new research may have discovered why.

Researchers of the study ‘Genetic Mechanisms Leading to Sex Differences Across...

Drug company Biogen has updated the possible side effects of MS drug Tecfidera, warning it may cause ‘significant liver injury’, which could require hospitalisation.

Liver injury has been...

A study has proposed MicroRNAs as biomarkers for the diagnosis, progression and...

According to recent study Multiple Sclerosis (MS) therapy alemtuzumab can trigger severe and unpredictable side effects. The team, led by Prof Dr Aiden Haghikia and Prof Dr Ralf Gold from the...

Toxic brain cells may drive many neurodegenerative disorders, a study has revealed.

A team led by researchers at the Stanford University School of Medicine has found that astrocytes, which...

Scientists who genetically silenced the transcription factor Nrf2 in a study of mice found it caused visual impairment and retinal ganglion cell (RGC) degeneration in MS.

The study,...

A recent study has found that early detection of Progressive Multifocal Leukoencephalopathy (PML) could decrease the damage to Multiple Sclerosis (MS) patients using...

Pages

Live Chat Software by Click4Assistance UK